老虎證券

BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data

Reuters
昨天
BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data

** Shares of cancer drug developer CG Oncology CGON.O rise 34% to $30

** On late Saturday, CGON said its bladder cancer therapy, cretostimogene grenadenorepvec, showed 42.3% of patients maintained complete response at 24 months for high-risk bladder cancer patients who failed previous treatments, in an ongoing late-stage study

** 97.3% of treated patients remained free from progression to more serious muscle-invasive bladder cancer at 24 months, co said

** Early data from another patient group, Cohort P, showed 90.5% of patients remained free from high-grade recurrence at both 3 and 9 months

** As of last close, stock down 22% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10